Abstract

In 2001, humanin – a small peptide – was first described and named a potential mitochondrial signalling molecule. Since its discovery a wide range of positive characteristics of this molecule have been described: antiapoptotic, cytoprotection through various mechanisms. This peptide is linked to age-related diseases like diabetes and atherosclerosis. The purpose of this article was to share information about humanin since it is a peptide serving as a target for potential medication design.